Skyscape Web Viewer : Elsevier’s Intravenous Medications : Main Index

View All
Immune globulin intravenous-ifas
Immune globulins aducanumab- Section 1 anifrolumab- Section
Immunizing agents cytomegalovirus immune globulin intravenous (human)- Section 1 hepatitis B immune globulin intravenous (human)- Section immune globulin intravenous- Section 2 immune globulin IV (passive)- Section Rho(D) immune globulin intravenous (human)- Section
Immunomodulators aldesleukin- Section 1 alemtuzumab- Section natalizumab- Section 1
Immunosuppressive agents anti-thymocyte globulin (rabbit)- Section basiliximab- Section belatacept (selective T-cell costimulation blocker)- Section cyclosporine- Section 1 dexamethasone sodium phosphate- Section 6 lymphocyte immune globulin- Section mycophenolate mofetil hydrochloride- Section panitumumab- Section tacrolimus- Section 1
Indocin IV
Indomethacin sodium
InFeD
Inflammatory bowel disease agents
Inflectra
Infliximab
Infliximab-abda
Infliximab-axxq
Infliximab-dyyb
Infliximab-qbtx
Influenza virus neuraminidase inhibitors
Infufer
Infugem
Infuvite Adult
Infuvite Pediatric
Injectafer
Inotropic agents digoxin- Section 2 dobutamine hydrochloride- Section 1 dopamine hydrochloride- Section 1 isoproterenol hydrochloride- Section 2 milrinone lactate- Section
Insulin human injection (regular)
Insulin-like growth factor-1 (IGR-IR)
Integrilin
Integrin receptor antagonists
Interferon receptor antagonists
Interleukin-2 Recombinant
Interleukin-5 antagonists
Intralipid 20% & 30%